New nerve block could ease pain for kids after tummy surgery

NCT ID NCT07540689

First seen May 01, 2026 · Last updated Jun 21, 2026 · Updated 9 times

Summary

This study tests whether a special nerve block called M-TAPA can reduce pain after laparoscopic abdominal surgery in children. Sixty kids aged 1 to 7 will be randomly assigned to get either the M-TAPA block or standard local anesthetic at the surgical cuts. The main goal is to see if the M-TAPA group has lower pain scores 6 hours after surgery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POST-OPERATIVE PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Kasralainy Hospital

    RECRUITING

    Cairo, Elmanial, 11562, Egypt

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

nerve block (M-TAPA)

What this could lead to

If it works, this could give children a more effective way to manage pain after laparoscopic surgery, reducing discomfort and the need for stronger painkillers.

What could go wrong

This is a small, early-stage trial with only 60 children, so results may not apply to all. The nerve block may not work better than the standard approach, and there is a small risk of side effects like bleeding or allergic reaction.

Conditions

The condition(s) this trial relates to.

Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.